BVF II GP LLC, Director Other, Director, Ten Percent Owner Other at Rain Therapeutics Inc. (RAIN), bought 3,420,716 shares at $5.83 ($19.9M) on 2022-11-08, disclosed to the SEC on 2022-11-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.83 | 54,857 | $320K | 1.6% |
| 2 | $5.83 | 54,857 | $320K | 1.6% |
| 3 | $5.83 | 685,330 | $4.0M | 20.0% |
| 4 | $5.83 | 685,330 | $4.0M | 20.0% |
| 5 | $5.83 | 970,171 | $5.7M | 28.4% |
| 6 | $5.83 | 970,171 |
| $5.7M |
| 28.4% |
| Total | $5.83 avg | 3,420,716 | $19.9M | 100% |
| Filing → |
| CGEM | BUY | 2022-04-05 | $5.9M | — | Filing → |
| CTIC | BUY | 2021-04-05 | $7.6M | — | Filing → |
| MRUS | BUY | 2021-03-24 | $1.8M | — | Filing → |